- This topic has 0 replies, 1 voice, and was last updated 9 years, 9 months ago by .
Viewing 1 post (of 1 total)
Viewing 1 post (of 1 total)
- You must be logged in to reply to this topic.
StocksDB › StocksDB › Ajanta Pharma Ltd › Ajanta Pharma – Downgrade To Sell: IndiaNivesh
Tagged: Ajanta Pharma, ICICI-Direct
We maintain our earnings estimates for FY15/FY16 and price target of Rs1,569 based on 17x FY16E EPS of Rs92.3. We remain confident on business model of AJP due to superior historical performance as well as key drivers in place to maintain momentum going forward. However, the current valuation of 24.1x FY15E and 20.5x FY16E earnings seems to have moved ahead of fundamentals. Hence we downgrade the stock to SELL from HOLD.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Stock Broker Research Reports
Download The Best Broker Research Reports On The Best Stocks